▁Eth 10.375
ical 2.748046875
▁Hold 9.7890625
ings 3.71484375
▁Target 11.4765625
s 1.46484375
▁the 7.6640625
▁US 5.84765625
▁Market 7.64453125
▁with 5.59765625
▁Sh 7.921875
arp 5.09375
▁R 4.2890625
ise 4.30078125
▁in 1.58984375
▁R 3.69140625
& 4.28125
D 2.177734375
▁Sp 5.8828125
ending 1.4794921875
▁▁ 11.421875
<0x0A> 5.6484375
<0x0A> 1.9296875
E 4.8828125
th 3.634765625
ical 0.5537109375
▁Hold 1.6728515625
ings 0.1771240234375
, 3.068359375
▁the 3.57421875
▁UK 4.89453125
- 2.318359375
based 0.12445068359375
▁bi 5.4765625
ote 0.306396484375
ch 0.6796875
▁company 1.0595703125
▁focused 4.109375
▁on 0.027130126953125
▁developing 1.814453125
▁gene 4.6328125
▁ther 0.69140625
ap 0.1136474609375
ies 0.00010693073272705078
▁for 0.48486328125
▁rare 1.287109375
▁dise 0.712890625
ases 0.0002238750457763672
, 0.214111328125
▁announced 2.451171875
▁a 2.662109375
▁ 3.49609375
7 3.0234375
5 1.0400390625
% 1.421875
▁increase 1.443359375
▁in 0.10693359375
▁research 4.40625
▁and 0.11767578125
▁development 0.0036563873291015625
▁sp 0.64794921875
ending 0.00013816356658935547
▁for 1.76171875
▁the 1.1337890625
▁coming 3.955078125
▁fis 2.53515625
cal 2.1338462829589844e-05
▁year 0.01232147216796875
▁as 3.43359375
▁it 1.00390625
▁looks 2.19921875
▁to 0.048980712890625
▁acceler 4.24609375
ate 0.0011692047119140625
▁appro 6.0859375
val 0.0011777877807617188
▁of 0.87158203125
▁its 0.6455078125
▁lead 1.7568359375
▁candidate 2.5
▁treatment 6.69140625
▁and 4.62109375
▁expand 2.041015625
▁into 1.4306640625
▁the 2.412109375
▁luc 3.744140625
r 4.112720489501953e-05
ative 0.00046706199645996094
▁US 1.0146484375
▁market 0.219970703125
. 0.12744140625
<0x0A> 0.38671875
<0x0A> 0.197509765625
The 1.7841796875
▁company 1.015625
▁will 3.359375
▁spend 1.4580078125
▁$ 1.841796875
2 1.751953125
5 1.98046875
0 1.619140625
▁million 0.46533203125
▁on 0.8310546875
▁R 1.2568359375
& 0.0129241943359375
D 0.0008521080017089844
▁in 1.4560546875
▁ 0.8671875
2 0.0023212432861328125
0 0.0004963874816894531
2 0.76171875
1 1.2802734375
, 0.55224609375
▁up 0.58984375
▁from 0.0780029296875
▁$ 0.316650390625
1 0.018890380859375
4 2.1328125
0 0.71533203125
▁million 0.09259033203125
▁last 1.646484375
▁year 0.00841522216796875
. 1.0751953125
▁The 2.2109375
▁bulk 3.755859375
▁of 0.1019287109375
▁the 0.5654296875
▁fund 3.232421875
ing 0.0182952880859375
▁will 0.34033203125
▁support 4.1875
▁late 6.34375
- 0.032440185546875
stage 0.0330810546875
▁clin 1.1435546875
ical 0.0004520416259765625
▁tri 0.26953125
als 4.7087669372558594e-05
▁of 0.9462890625
▁its 1.126953125
▁experimental 4.71484375
▁gene 0.41015625
▁ther 0.07550048828125
apy 0.257080078125
▁for 0.84912109375
▁sp 2.91015625
inal 0.012298583984375
▁mus 0.003681182861328125
cular 0.0038089752197265625
▁at 0.000942230224609375
ro 0.0015392303466796875
phy 0.0003757476806640625
▁( 1.1611328125
S 0.083251953125
MA 0.0003509521484375
), 0.46533203125
▁a 1.2509765625
▁rare 1.3291015625
▁neur 2.123046875
om 0.0038776397705078125
us 0.0005006790161132812
cular 0.0012493133544921875
▁disease 0.69482421875
▁that 0.73095703125
▁is 3.40234375
▁the 2.23046875
▁leading 1.0634765625
▁gen 1.5517578125
etic 0.0035076141357421875
▁cause 0.1129150390625
▁of 0.0117340087890625
▁infant 1.4677734375
▁death 0.6953125
. 0.72509765625
▁If 5.20703125
▁approved 1.1630859375
, 0.321533203125
▁the 0.64794921875
▁treatment 1.462890625
▁would 0.93701171875
▁be 0.54296875
▁the 0.60595703125
▁first 0.11773681640625
▁gene 1.7587890625
▁ther 0.032257080078125
apy 0.00476837158203125
▁for 1.1171875
▁S 0.7197265625
MA 0.0001552104949951172
. 1.5380859375
<0x0A> 0.323974609375
<0x0A> 0.034149169921875
“ 24.890625
This 9.046875
▁boost 5.9375
ed 3.306640625
▁invest 2.353515625
ment 0.10821533203125
▁in 2.208984375
▁research 1.48046875
▁fund 7.01171875
ing 0.041900634765625
▁demonstr 7.14453125
ates 0.0006613731384277344
▁our 6.48046875
▁commit 0.95166015625
ment 0.0014047622680664062
▁to 0.048126220703125
▁bringing 2.990234375
▁potentially 4.95703125
▁life 0.260498046875
- 0.03729248046875
ch 0.248291015625
anging 7.557868957519531e-05
▁ther 1.078125
ap 0.007099151611328125
ies 4.076957702636719e-05
▁to 0.1024169921875
▁patients 0.4794921875
▁as 2.130859375
▁quickly 0.3037109375
▁as 0.053680419921875
▁possible 0.037200927734375
,” 24.21875
▁said 5.62109375
▁Eth 2.228515625
ical 0.01088714599609375
▁Hold 0.0180511474609375
ings 0.0153045654296875
▁CE 0.95703125
O 0.001064300537109375
▁Emma 6.859375
▁Thompson 5.61328125
. 1.3798828125
▁“ 24.03125
We 5.7734375
▁have 2.19921875
▁prom 11.78125
ising 0.0008397102355957031
▁treat 4.1640625
ments 0.0002720355987548828
▁in 0.73779296875
▁our 1.9208984375
▁pipeline 0.1390380859375
▁for 1.607421875
▁S 1.923828125
MA 0.0025177001953125
▁and 1.083984375
▁other 0.9521484375
▁rare 0.3916015625
▁dise 0.251220703125
ases 0.0003485679626464844
, 0.935546875
▁and 0.52783203125
▁now 5.22265625
▁is 1.068359375
▁the 0.12445068359375
▁time 0.50439453125
▁to 0.09844970703125
▁drive 4.84375
▁them 2.08203125
▁across 5.65625
▁the 0.12164306640625
▁finish 0.09747314453125
▁line 0.0025653839111328125
.” 23.1875
<0x0A> 1.259765625
<0x0A> 0.1326904296875
The 2.51953125
▁sur 6.61328125
ge 0.049163818359375
▁in 0.1199951171875
▁R 1.34765625
& 0.01169586181640625
D 0.000896453857421875
▁sp 0.177978515625
ending 0.00025844573974609375
▁comes 1.1982421875
▁as 0.50048828125
▁Eth 1.2431640625
ical 0.0019388198852539062
▁Hold 0.007183074951171875
ings 0.00704193115234375
▁ram 3.908203125
ps 0.00021326541900634766
▁up 0.012054443359375
▁efforts 1.890625
▁to 0.0748291015625
▁break 4.6015625
▁into 0.096435546875
▁the 0.055267333984375
▁US 1.0166015625
▁health 4.49609375
care 0.2001953125
▁market 0.121337890625
. 0.76953125
▁The 0.9306640625
▁US 5.12890625
▁accounts 3.125
▁for 0.0013599395751953125
▁nearly 2.736328125
▁half 1.2685546875
▁of 0.09637451171875
▁global 2.115234375
▁bi 3.341796875
ote 0.260498046875
ch 0.11572265625
▁reven 3.755859375
ues 0.0002989768981933594
, 0.619140625
▁but 1.9716796875
▁Eth 3.599609375
ical 0.0012655258178710938
▁Hold 0.01454925537109375
ings 0.006229400634765625
▁currently 5.62890625
▁has 0.72119140625
▁no 0.65966796875
▁presence 2.47265625
▁in 0.986328125
▁the 0.09454345703125
▁country 0.9296875
. 0.398681640625
▁Its 3.958984375
▁S 3.701171875
MA 0.0176239013671875
▁treatment 1.4384765625
▁is 1.1494140625
▁approved 3.427734375
▁in 0.669921875
▁Europe 1.287109375
, 0.888671875
▁but 1.400390625
▁US 4.33203125
▁regul 1.25
atory 2.9453125
▁appro 0.5087890625
val 0.00017726421356201172
▁would 2.0859375
▁open 3.193359375
▁up 1.2490234375
▁a 1.4228515625
▁much 3.62109375
▁larger 0.380615234375
▁commercial 5.2578125
▁opportunity 0.58544921875
. 0.366455078125
▁The 2.7109375
▁company 0.29833984375
▁plans 2.576171875
▁to 0.02984619140625
▁file 2.44140625
▁for 0.615234375
▁US 2.21484375
▁appro 0.69580078125
val 1.0848045349121094e-05
▁of 1.6650390625
▁the 1.3017578125
▁S 2.08984375
MA 0.007350921630859375
▁ther 1.5966796875
apy 0.0057830810546875
▁by 1.994140625
▁mid 3.435546875
- 0.0638427734375
2 0.224853515625
0 0.0015993118286132812
2 0.0004858970642089844
1 1.015625
. 0.63037109375
<0x0A> 0.152587890625
<0x0A> 0.030181884765625
To 6.68359375
▁support 2.830078125
▁its 1.2265625
▁US 1.482421875
▁expansion 1.22265625
, 0.31005859375
▁Eth 0.2374267578125
ical 0.0006103515625
▁Hold 0.0035076141357421875
ings 0.0037593841552734375
▁also 3.326171875
▁announced 1.1416015625
▁the 1.876953125
▁opening 4.453125
▁of 0.01165771484375
▁its 2.365234375
▁US 1.9345703125
▁headquarters 0.366943359375
▁in 0.2646484375
▁Boston 1.81640625
, 1.068359375
▁a 3.859375
▁hub 4.91796875
▁for 0.22607421875
▁bi 2.7109375
ote 0.044921875
ch 0.1309814453125
▁innov 1.9794921875
ation 0.10540771484375
. 1.056640625
▁The 0.64990234375
▁company 0.7333984375
▁has 2.19140625
▁h 3.126953125
ired 0.00067901611328125
▁several 2.412109375
▁execut 2.44140625
ives 0.00015032291412353516
▁with 2.634765625
▁experience 0.67529296875
▁bringing 6.734375
▁gene 0.90771484375
▁ther 0.042266845703125
ap 0.0855712890625
ies 1.6927719116210938e-05
▁to 0.12152099609375
▁market 0.492431640625
▁to 5.55859375
▁staff 5.5703125
▁its 1.2099609375
▁US 1.376953125
▁office 1.88671875
. 0.5732421875
▁▁ 4.87109375
<0x0A> 0.0631103515625
<0x0A> 0.12091064453125
“ 21.53125
The 1.6826171875
▁US 1.8818359375
▁launch 6.71875
▁is 1.5703125
▁a 0.91650390625
▁mil 4.0546875
estone 0.0001386404037475586
▁we 5.9609375
▁have 1.16796875
▁been 0.26220703125
▁moving 10.203125
▁toward 1.5185546875
▁for 0.1798095703125
▁years 1.98046875
▁now 3.50390625
. 2.076171875
▁With 4.171875
▁a 3.150390625
▁proven 4.47265625
▁treatment 2.490234375
, 1.95703125
▁a 2.8125
▁newly 6.30859375
▁bol 7.9765625
ster 0.0009775161743164062
ed 0.00010776519775390625
▁team 3.783203125
, 0.67919921875
▁and 0.1177978515625
▁strong 3.80859375
▁financial 2.52734375
▁backing 0.234375
, 0.2113037109375
▁we 0.380859375
▁are 0.642578125
▁ready 1.6865234375
▁to 0.2347412109375
▁introduce 6.953125
▁Eth 1.509765625
ical 0.0093994140625
▁Hold 0.01258087158203125
ings 0.013458251953125
▁to 0.6162109375
▁American 5.3046875
▁patients 0.798828125
▁and 0.449462890625
▁share 5.296875
hold 0.031646728515625
ers 6.413459777832031e-05
,” 22.34375
▁said 1.0625
▁M 6.46875
s 0.478759765625
. 0.28955078125
▁Thompson 0.033355712890625
. 0.728515625
<0x0A> 0.472900390625
<0x0A> 0.0693359375
E 2.306640625
th 0.10821533203125
ical 0.0012445449829101562
▁Hold 0.005832672119140625
ings 0.005084991455078125
’ 24.53125
▁stock 9.0
▁price 2.658203125
▁rose 3.349609375
▁ 0.68798828125
4 2.39453125
% 1.3203125
▁on 1.80859375
▁the 0.65869140625
▁news 0.427490234375
▁of 1.705078125
▁its 1.2763671875
▁increased 2.19921875
▁R 0.496337890625
& 0.0063629150390625
D 0.0007052421569824219
▁sp 0.2230224609375
ending 0.00030875205993652344
▁and 2.453125
▁planned 5.63671875
▁US 0.458984375
▁launch 1.3056640625
. 0.39111328125
▁In 5.1171875
vest 1.609375
ors 0.050201416015625
▁see 5.21875
▁an 4.44921875
▁opportunity 0.7744140625
▁for 1.2685546875
▁the 0.6787109375
▁company 0.50634765625
▁to 0.2138671875
▁significantly 5.8046875
▁expand 1.36328125
▁re 4.2734375
venue 0.0038509368896484375
▁if 5.4296875
▁it 1.2744140625
▁can 0.6103515625
▁gain 3.275390625
▁US 2.435546875
▁appro 0.418701171875
val 1.33514404296875e-05
▁for 0.46826171875
▁its 0.206787109375
▁S 0.77685546875
MA 0.0022735595703125
▁treatment 1.01171875
▁and 1.91796875
▁other 3.03515625
▁experimental 4.57421875
▁ther 1.0263671875
ap 0.0007276535034179688
ies 3.4689903259277344e-05
▁in 3.05078125
▁the 0.96923828125
▁coming 1.3974609375
▁years 0.2305908203125
. 0.12841796875
▁With 7.69921875
▁a 1.55078125
▁full 6.51953125
▁pipeline 2.07421875
▁of 0.50439453125
▁gene 2.8203125
▁ther 0.02313232421875
ap 0.055419921875
ies 3.695487976074219e-05
▁and 2.224609375
▁now 7.5
▁the 3.02734375
▁means 4.79296875
▁to 0.0279388427734375
▁bring 1.4912109375
▁them 0.15283203125
▁to 0.093505859375
▁market 0.23046875
, 0.183837890625
▁Eth 0.421142578125
ical 0.0008845329284667969
▁Hold 0.005107879638671875
ings 0.004673004150390625
▁is 1.451171875
▁po 1.7490234375
ised 0.00015401840209960938
▁to 0.279296875
▁become 1.22265625
▁an 3.294921875
▁emer 3.1875
ging 0.0034809112548828125
▁player 2.666015625
▁in 0.036346435546875
▁the 0.223388671875
▁global 2.814453125
▁bi 0.253173828125
ote 0.0121917724609375
ch 0.09619140625
▁industry 0.60791015625
. 0.10919189453125
